Showing results (241-250 of 253) with videos related to
Sort By:
Pageof 26
Transplantation and Cellular Therapy|June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall SurvivalGurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.Blood|April 29, 2024
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F Krakow, Michelle Brault, Corinne Summers, et al.Journal of Critical Care|May 4, 2020
The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicitiesCristina Gutierrez, Anne Rain T Brown, Megan M Herr, et al.JAMA Oncology|October 12, 2023
Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled TrialYongwoo David Seo, Hailing Lu, Graeme Black, et al.Blood Advances|December 3, 2024
Development and validation of predictive models of early immune effector cell-associated hematotoxicityEmily C Liang, Jennifer J Huang, Andrew J Portuguese, et al.The Journal of Clinical Investigation|September 22, 2022
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell targetQuy Le, Brandon Hadland, Jenny L Smith, et al.Immunity|February 14, 2024
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networksCarla A Jaeger-Ruckstuhl, Yun Lo, Elena Fulton, et al.Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Unveiling the autoreactome: Proteome-wide immunological fingerprints reveal the promise of plasma cell depleting therapyAaron Bodansky, David Jl Yu, Alysa Rallistan, et al.The Journal of Clinical Investigation|May 16, 2024
Unveiling the proteome-wide autoreactome enables enhanced evaluation of emerging CAR T cell therapies in autoimmunityAaron Bodansky, David Jl Yu, Alysa Rallistan, et al.Transplantation and Cellular Therapy|June 24, 2026
Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell LymphomaNausheen Ahmed, Alaa Ali, Soyoung Kim, et al.Pageof 26